Detalhe da pesquisa
1.
Evidence of SARS-CoV-2 convergent evolution in immunosuppressed patients treated with antiviral therapies.
Virol J
; 21(1): 105, 2024 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38715113
2.
Modeling suggests that virion production cycles within individual cells is key to understanding acute hepatitis B virus infection kinetics.
PLoS Comput Biol
; 19(8): e1011309, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37535676
3.
Understanding Hepatitis B Virus Dynamics and the Antiviral Effect of Interferon Alpha Treatment in Humanized Chimeric Mice.
J Virol
; 95(14): e0049220, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33910953
4.
Modeling-Based Response-Guided Glecaprevir-Pibrentasvir Therapy for Chronic Hepatitis C to Identify Patients for Ultrashort Treatment Duration.
J Infect Dis
; 222(7): 1165-1169, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32363394
5.
Intracellular Hepatitis C Virus Modeling Predicts Infection Dynamics and Viral Protein Mechanisms.
J Virol
; 92(11)2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29563295
6.
Acute hepatitis B virus infection in humanized chimeric mice has multiphasic viral kinetics.
Hepatology
; 68(2): 473-484, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29572897
7.
Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis.
Liver Int
; 39(5): 826-834, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30499631
8.
HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvir.
J Hepatol
; 64(6): 1232-9, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26907973
9.
Quantification of Hepatitis C Virus Cell-to-Cell Spread Using a Stochastic Modeling Approach.
J Virol
; 89(13): 6551-61, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25833046
10.
Identification of transferrin receptor 1 as a hepatitis C virus entry factor.
Proc Natl Acad Sci U S A
; 110(26): 10777-82, 2013 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-23754414
11.
Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life.
Proc Natl Acad Sci U S A
; 110(10): 3991-6, 2013 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23431163
12.
Determining the involvement and therapeutic implications of host cellular factors in hepatitis C virus cell-to-cell spread.
J Virol
; 88(9): 5050-61, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24554660
13.
Unexpected structural features of the hepatitis C virus envelope protein 2 ectodomain.
J Virol
; 88(18): 10280-8, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24991010
14.
Hepatitis delta virus RNA decline post inoculation in human NTCP transgenic mice is biphasic.
bioRxiv
; 2023 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36824865
15.
Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasic.
mBio
; 14(4): e0100823, 2023 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37436080
16.
Identification of hepatitis C virus inhibitors targeting different aspects of infection using a cell-based assay.
Antimicrob Agents Chemother
; 56(12): 6109-20, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22948883
17.
Permissiveness of human hepatoma cell lines for HCV infection.
Virol J
; 9: 30, 2012 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-22273112
18.
Sequencing during Times of Change: Evaluating SARS-CoV-2 Clinical Samples during the Transition from the Delta to Omicron Wave.
Viruses
; 14(7)2022 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35891388
19.
Antibody Response to SARS-CoV-2 Infection and Vaccination in COVID-19-naïve and Experienced Individuals.
Viruses
; 14(2)2022 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35215962
20.
A vesicular stomatitis virus-based hepatitis B virus vaccine vector provides protection against challenge in a single dose.
J Virol
; 84(15): 7513-22, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20504927